Researchers uncover new details linking stress, fat metabolism

January 06, 2016

GAINESVILLE, Fla. -- If you're under constant stress and can't lose weight, there might be a protein to blame.

In cell and mouse model experiments, University of Florida Health researchers have discovered that chronic stress stimulates production of betatrophin, a protein that then goes on to inhibit an enzyme involved in fat metabolism. Those findings were published this month in the journal BBA Molecular and Cell Biology of Lipids.

Its role as a stress-related protein brings new attention to betatrophin, which was once hailed by researchers elsewhere as a breakthrough therapy for diabetes, but later deemed ineffective.

While the latest properties of betatrophin have yet to be tested in a clinical setting, one researcher said the findings have potential implications for humans.

"Betatrophin reduces the body's ability to break down fat, underscoring a link between chronic stress and weight gain," said Li-Jun Yang, M.D., a professor and lead investigator in the UF College of Medicine's department of pathology, immunology and laboratory medicine.

In the present study, mouse models experiencing metabolic stress produced significantly more betatrophin, and their normal fat-burning processes slowed down markedly. Such observations are significant because they shed new light on the biological mechanisms linking stress, betatrophin and fat metabolism, Yang said.

Betatrophin set the scientific world abuzz in 2013, when a Harvard University study suggested it could increase the number of insulin-producing beta cells in people with diabetes. Other researchers later concluded that it had no such effect.

Now it seems that betatrophin has an important, if less celebrated, role: The results provide experimental evidence that stress makes it harder to break down body fat, according to Yang and co-first author Yuan Zhang, M.D., who is completing her Ph.D. research at UF as part of the College of Medicine's joint training program with the Second Hospital of Shandong University in Jinan, China. Researchers there collaborated with Yang's group, and this study was funded in part by the Lupus Research Institute and the China Scholarship Council.

Yang's group made several novel findings, including that betatrophin is a stress-related protein. They also discovered why more betatrophin leads to less fat burning: It suppresses adipose triglyceride lipase, an enzyme that breaks down stored fat.

Experiments on cells derived from mice and humans were first used to establish betatrophin's role in body fat regulation, Yang said. Next, researchers studied how betatrophin levels increased as mouse models experienced environmental and metabolic stress. Both types of stress boosted betatrophin production in fat tissue and the liver. That finding established betatrophin is a stress-related protein, Yang said.

While researchers have yet to test betatrophin's effect on fat metabolism in humans, Yang said the new findings explain how reducing stress can be beneficial. While short-term mild stress can help people perform better and get through difficult situations, long-term stress can be far more detrimental.

"Stress causes you to accumulate more fat, or at least slows down fat metabolism. This is yet another reason why it's best to resolve stressful situations and to pursue a balanced life," Yang said.
-end-


University of Florida

Related Diabetes Articles from Brightsurf:

New diabetes medication reduced heart event risk in those with diabetes and kidney disease
Sotagliflozin - a type of medication known as an SGLT2 inhibitor primarily prescribed for Type 2 diabetes - reduces the risk of adverse cardiovascular events for patients with diabetes and kidney disease.

Diabetes drug boosts survival in patients with type 2 diabetes and COVID-19 pneumonia
Sitagliptin, a drug to lower blood sugar in type 2 diabetes, also improves survival in diabetic patients hospitalized with COVID-19, suggests a multicenter observational study in Italy.

Making sense of diabetes
Throughout her 38-year nursing career, Laurel Despins has progressed from a bedside nurse to a clinical nurse specialist and has worked in medical, surgical and cardiac intensive care units.

Helping teens with type 1 diabetes improve diabetes control with MyDiaText
Adolescence is a difficult period of development, made more complex for those with Type 1 diabetes mellitus (T1DM).

Diabetes-in-a-dish model uncovers new insights into the cause of type 2 diabetes
Researchers have developed a novel 'disease-in-a-dish' model to study the basic molecular factors that lead to the development of type 2 diabetes, uncovering the potential existence of major signaling defects both inside and outside of the classical insulin signaling cascade, and providing new perspectives on the mechanisms behind insulin resistance in type 2 diabetes and possibly opportunities for the development of novel therapeutics for the disease.

Tele-diabetes to manage new-onset diabetes during COVID-19 pandemic
Two new case studies highlight the use of tele-diabetes to manage new-onset type 1 diabetes in an adult and an infant during the COVID-19 pandemic.

Genetic profile may predict type 2 diabetes risk among women with gestational diabetes
Women who go on to develop type 2 diabetes after having gestational, or pregnancy-related, diabetes are more likely to have particular genetic profiles, suggests an analysis by researchers at the National Institutes of Health and other institutions.

Maternal gestational diabetes linked to diabetes in children
Children and youth of mothers who had gestational diabetes during pregnancy are at increased risk of diabetes themselves, according to new research published in CMAJ (Canadian Medical Association Journal).

Two diabetes medications don't slow progression of type 2 diabetes in youth
In youth with impaired glucose tolerance or recent-onset type 2 diabetes, neither initial treatment with long-acting insulin followed by the drug metformin, nor metformin alone preserved the body's ability to make insulin, according to results published online June 25 in Diabetes Care.

People with diabetes visit the dentist less frequently despite link between diabetes, oral health
Adults with diabetes are less likely to visit the dentist than people with prediabetes or without diabetes, finds a new study led by researchers at NYU Rory Meyers College of Nursing and East Carolina University's Brody School of Medicine.

Read More: Diabetes News and Diabetes Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.